Evolving Biotechnologies with Olga Troya...

<p>A labor and delivery nurse who ran Senate healthcare policy now manages $1.7 trillion in federal health spending—and she runs her team like a startup.</p><p>Steph Carlton, Chief of Staff and Deputy Administrator at CMS, reveals the OKRs driving Medicare and Medicaid, why they' ... Show More

<p>Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. </p><p>In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma compa ... Show More

<p>Josh Weiner left Meta to return to CVS Health with two painful realizations: consumers don't manage their health—they expect it, and the healthcare market fundamentally violates every principle of economics. In this conversation with a16z's Julie Yoo, the CVS Senior VP explain ... Show More

<p>In this episode, vanguard geneticist <a href='https://wyss.harvard.edu/team/core-faculty/george-church/'>Dr. George Church</a> recounts his storied career from his early fascination with computers and science to his pioneering work in genomics and synthetic biology. Dr. Church ... Show More

<p>Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the k ... Show More

<p>Welcome to <a href="https://a16z.com/2020/09/22/biology-aging/" target="_blank">the first episode of Bio Eats World</a>, a brand <a href="https://a16z.com/bio-eats-world-podcast/" target="_blank">new podcast</a> all about how biology <i>is</i> technology. Bio is breaking out o ... Show More

<p>"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between wh ... Show More

<p>"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between wh ... Show More

<p>"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between wh ... Show More

In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ... Show More

Cours du 14 février 2007 - 2ème heureCollège de FranceLa biotechnologie va permettre dans l'avenir d'améliorer considérablement le traitement des malades. Elle va permettre d'augmenter l'espérance de vie. Mais cette industrie devra résoudre certains problèmes éthiques comme le cl ... Show More

اليوم يلتقي رها بالدكتورة دانا السليمان، امرأة سعودية حازت على جوائز عديدة تعمل على تطوير تقنيات البيوتكنولوجيا من الجيل القادم.دانا هي أستاذة مساعدة في علوم المواد والهندسة الحيوية في جامعة الملك عبد الله للعلوم والتقنية (كاوست)، وهي تعمل على تطوير تقنيات بيوتكنولوجيا يمكنها اكت ... Show More

<p>In this episode of the AI Grand Rounds podcast, <a href='https://www.insitro.com/leadership/daphne-koller/'>Dr. Daphne Koller</a> charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued ... Show More